US FDA approves Orca Bio's blood cancer therapy

June 30 (Reuters) - The U.S. Food and Drug Administration has approved Orca Bio's cell therapy for the treatment of certain ...

FDA approves Artivion’s AMDS device PMA

Artivion has received premarket approval application (PMA) clearance from the US Food and Drug Administration (FDA) for the ...
Las Vegas Sun

Orca Bio’s TREGZI™ Receives U.S. FDA Approval as First and Only Precision-Engineered Cell Therapy for Allogeneic Transplant in Adults with Hematological Malignancies

Orca Bio, a commercial-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the U.S. Food and Drug Administration (FDA) has ...

New sunscreen ingredient wins FDA approval after years of delay

A sunscreen ingredient that's been available in Europe, Japan and South Korea for years has finally been approved by the FDA for sale in the U.S.

Arcutis Biotherapeutics' Psoriasis Cream Gets FDA Approval for Young Children

The Food and Drug Administration approved the use of Arcutis Biotherapeutics' Zoryve plaque psoriasis cream for children as young as age two. The company on Monday said the FDA approved a supplemental ...
Fierce Pharma

Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war

The game is on for TROP2 antibody-drug conjugates in first-line triple-negative breast cancer. | Less than a month after an approval for Daiichi Sankyo and AstraZeneca’s Datroway for front-line TNBC ...
Healio

FDA expands approval for Zoryve cream 0.3% to children with psoriasis as young as 2 years

The FDA approved Zoryve cream 0.3% for the treatment of plaque psoriasis in children as young as 2 years, Arcutis announced ...

FDA approves new sunscreen ingredient used for years in Europe and Asia

A new sunscreen ingredient used for years in Europe and Asia was approved for use in the US. The ingredient is safer than some currently in use, experts say.
Tech Times

Anthropic Livestreams AI for Science Pitch as No AI Drug Has Won FDA Approval

Anthropic AI for Science event livestreams today as the company pitches Claude to pharma and biotech leaders. The session ...
Asianet Newsable on MSN

UNCY stock clocks worst day in a year — analysts keep buy ratings despite ‘5-12 month delay’ in drug approval

Unicycive Therapeutics said on Tuesday that the U.S. Food and Drug Administration has again refused to approve its drug ...

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency

The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data ...

50% of peptide users are taking compounds not approved for human use. Most don't know it

Hone Health reports that 50% of peptide users mistakenly believe they take FDA-approved compounds, highlighting risks of ...